Results 21 to 30 of about 12,257,906 (257)

Experience and Progress Processing Policy of Simultaneous Multiple Primary 
Lung Cancer

Chinese Journal of Lung Cancer, 2018
Background and objective Simultaneity multiple primary lung cancer always is a rare disease, but in recent years due to the progress of the diagnosis and treatment means detection rate increased.
Liankui HAN, Shugeng GAO, Fengwei TAN, Ziran ZHAO, Peng SONG   +4 more
doaj   +1 more source

Synchronous triple primary lung cancer with three different histological subtypes in the same lobe: A case report

Thoracic Cancer, 2021
Although the number of patients diagnosed with synchronous multiple primary lung cancer is growing because of increased screening and improved imaging technology, synchronous triple primary lung cancer with different histological tumor subtypes occurring
Tsutomu Koyama, Kimihiro Shimizu, Takeshi Uehara, Shunichiro Matsuoka, Tetsu Takeda, Kyoko Yamada, Takashi Eguchi, Kazutoshi Hamanaka, Kenji Sano   +8 more
doaj   +1 more source

A rare case of synchronous multiple primary lung cancer with different responses to gefitinib

Respiratory Medicine Case Reports, 2020
Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors.
Che-Chi Liao, Yu-Sen Lin, Yu-Chao Lin, Chiao-Jen Cheng, Shuo-Chueh Chen   +4 more
doaj   +1 more source

Symptom lead time distribution in lung cancer:natural history and prospects for early diagnosis [PDF]

, 2014
BACKGROUND: Before their diagnosis, patients with cancer present in primary care more frequently than do matched controls. This has raised hopes that earlier investigation in primary care could lead to earlier stage at diagnosis.METHODS: We re-analysed ...
Ades, Anthony E., Welton, Nicky J., Hamilton, William, Biswas, Mousumi   +3 more
core   +1 more source

Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis

BMC Pulmonary Medicine, 2023
Background PSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate 18 F-PSMA uptake, including primary lung cancer.
Yuan Hu, Peng Wang, Wenli Dai
doaj   +1 more source

Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer [PDF]

, 2011
Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome.
Derek Grose MRCP, FRCR, Robert Milroy, Grose, Derek, Milroy, Robert   +3 more
core   +1 more source

Familial multiple primary lung cancers: a population-based analysis from Sweden

, 2005
Multiple primary cancers arise because of inherited or acquired deficiencies, and their causes may depend on the first primary cancer, or they may be entirely independent.
Hemminki, K, Li, X
core   +1 more source

Unlocking biomarker discovery: Large scale application of aptamer proteomic technology for early detection of lung cancer [PDF]

, 2010
Lung cancer is the leading cause of cancer deaths, because ~84% of cases are diagnosed at an advanced stage. Worldwide in 2008, ~1.5 million people were diagnosed and ~1.3 million died – a survival rate unchanged since 1960.
Alex Stewart, Stewart, A, Joel L Weissfeld, William L. Bigbee, Mehan Mike, Rom, William N, Stewart, Alex, Gold Larry, Miller, YE, Edward N. Brody, William N Rom, Weissfeld, JL, Harvey I Pass, Siegfried, JM, Pass Harvey I., Stephen Williams, Siegfried, Jill M, Walker, Jeffrey J, Walker Jeffrey J., Bigbee, William L, William L Bigbee, Pass, Harvey I, Rachel M Ostroff, Ostroff, RM, Weissfeld Joel L., Gold, Larry, Bigbee William L., York E. Miller, Zichi Dom, York E Miller, Weissfeld, Joel L, William N. Rom, Gold, L, Franklin Wilbur, Joel L. Weissfeld, Edward N Brody, Franklin, Wilbur, Williams Stephen, Rom, WN, Miller York E., Jeffrey J Walker, Franklin, W, Zichi, D, Mehan, M, Miller, York E, Harvey I. Pass, Brody, EN, Bigbee, WL, Ostroff, Rachel M, Walker, JJ, Rom William N., Williams, Stephen, Dom Zichi, Stewart Alex, Pass, HI, Mehan, Mike, Wilbur Franklin, Brody Edward N., Siegfried Jill M., Mike Mehan, Williams, S, Zichi, Dom, Jill M Siegfried, Rachel M. Ostroff, Ostroff Rachel M., Jeffrey J. Walker, Jill M. Siegfried, Larry Gold, Brody, Edward N   +68 more
core   +1 more source

The long-term outcomes of metachronous tumors for non-small cell lung cancer

Clinical Surgical Oncology
Background: We aimed to identify prognostic factors for mortality and survival in patients operated on for metachronous primary lung cancer (MPLC).
Celalettin Kocaturk, Cem Emrah Kalafat, Celal Bugra Sezen, Mustafa Vedat Dogru, Levent Cansever, Muzaffer Metin, Mehmet Ali Bedirhan   +6 more
doaj   +1 more source

Variation in the use of chemotherapy in lung cancer. [PDF]

, 2007
Factors influencing the use of chemotherapy for the initial (6 months) treatment of lung cancer in South East England were investigated. The variables explored as possibly influencing the use of chemotherapy were sex, age, the year of diagnosis, the type
Moller, H; id_orcid, Adatia, R, Jack, R, H Møller, Patel, Nilesh, N Patel, A Mellemgaard, Møller, H, Mellemgaard, A, Patel, N, R Adatia, Jack, Ruth, R Jack   +12 more
core   +1 more source